MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0026119
Indigrammy Pharmaceuticals Private Limited
Indigrammy Pharmaceuticals Private Limited - business services in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹34.18 Lakh
▲ 17% YoY
Net profit · FY 2025
₹92,167
Net margin 2.7%
EBITDA · FY 2025
₹92,167
EBITDA margin 2.7%
Authorised capital
₹50,000
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Indigrammy Pharmaceuticals Private Limited
Data last updated:
Indigrammy Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 20 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC348322. Its GSTIN is 09AAFCI8646C1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It is led by directors Abhishek Tiwari and Aman Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 33 Building Nok 15 Parera Nagar, Thane, Maharashtra, India – 401208.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.18 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹92,167 (net margin 2.7%) and EBITDA of ₹92,167 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 69% over three years.
Indigrammy Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0026119).
Company details
CIN U74999MH2020PTC348322
Registration Number 348322
Incorporation Date 20 October 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0026119
Key People
Abhishek Tiwari Director Aman Mishra Director Recognitions & Rankings of Indigrammy Pharmaceuticals
Contact details
Indigrammy Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 33 Building Nok 15 Parera Nagar, Thane, Maharashtra, India – 401208
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Indigrammy Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Indigrammy Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Indigrammy Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indigrammy Pharmaceuticals Private Limited, buy the company report.
Financials of Indigrammy Pharmaceuticals Private Limited
FY 2025 filings availableIndigrammy Pharmaceuticals Private Limited reported revenue of ₹34.18 Lakh (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹34.18 Lakh ▲ 17%
Net profit · FY 2025
₹92,167 margin 2.7%
EBITDA · FY 2025
₹92,167 margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 69%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 93%
Revenue has grown at a compounded annual rate (CAGR) of 69% over three years, including 17% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92,167 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92,167 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indigrammy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indigrammy Pharmaceuticals Private Limited
Indigrammy Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Tiwari | Director | 09 Apr 2024 | 2 Years 7 Months | Current |
| Aman Mishra | Director | 20 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Indigrammy Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunbiosmith Pharmaceuticals Private Limited | ₹34.24 Lakh (FY 2025) | 6.0% | Dehradun, Uttarakhand, India | |||
| Goodness Pharmaceuticals Private Limited | ₹34.21 Lakh (FY 2022) | 6.0% | Aligarh, Uttar Pradesh, India | |||
| Craicean Pharmaceuticals Private Limited | ₹34.19 Lakh (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Indigrammy Pharmaceuticals Private Limitedthis company | ₹34.18 Lakh (FY 2025) | ₹92,167 | 2.7% | 17.0% | Thane, Maharashtra, India | |
| Solway Pharmaceuticals Private Limited | ₹34.16 Lakh (FY 2025) | -11.0% | Ambala Cantt, Haryana, India | |||
| Etios Pharmaceuticals Private Limited | ₹34.15 Lakh (FY 2024) | -12.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Indigrammy Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indigrammy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indigrammy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indigrammy Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCI8646C1ZF | Uttar Pradesh | Active | 02 Mar 2021 |
To see the full GST registrations and return filing status of Indigrammy Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indigrammy Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Abhishek Tiwari was appointed as Director on 09 Apr 2024.
AGM
Indigrammy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Indigrammy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Abhishek Tiwari was appointed as Director.
Ceased
Badri Nath Mishra ceased to be Director.
Ceased
Vijay Laxmi ceased to be Director.
Appointed
Aman Mishra was appointed as Director.
Incorporation
20 Oct 2020
Indigrammy Pharmaceuticals Private Limited was registered on 20 Oct 2020 with Roc Mumbai Ii & aged 6 years 24 days as per MCA records.
Frequently asked questions
Indigrammy Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 20 October 2020 (6+ years old) and is registered under CIN U74999MH2020PTC348322.
Indigrammy Pharmaceuticals has 2 current directors:
- Abhishek Tiwari - Director
- Aman Mishra - Director
The latest financial statements of Indigrammy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Indigrammy Pharmaceuticals is 09AAFCI8646C1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Indigrammy Pharmaceuticals is U74999MH2020PTC348322. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indigrammy Pharmaceuticals was incorporated on 20 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Indigrammy Pharmaceuticals by revenue are Sunbiosmith Pharmaceuticals Private Limited, Goodness Pharmaceuticals Private Limited, Craicean Pharmaceuticals Private Limited, Solway Pharmaceuticals Private Limited, Etios Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Tiwari was appointed as Director on 09 Apr 2024. Badri Nath Mishra ceased to be Director on 09 Apr 2024. Vijay Laxmi ceased to be Director on 01 Sep 2022. Indigrammy Pharmaceuticals has 4 board changes on record in total.
Yes, Indigrammy Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0026119).
The registered office of Indigrammy Pharmaceuticals is at Flat No 33 Building Nok 15 Parera Nagar, Thane, Maharashtra, India – 401208.
Indigrammy Pharmaceuticals operates in the business services industry, in the other services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages